AORT — ARTIVION, INC.
—
NYSE ·
Health Care ·
Health Care Equipment & Supplies ·
CIK 784199 ·
Last close
$18.27
Market Cap
$891.39M
52W High
$48.25
52W Low
$18.12
ADV30
704,675
Next earnings
2026-11-05
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Sep 2026 | 123,790,000 | 75,977,000 | 2,947,000 | -7,926,000 | 1,042,088,000 | 48,399,000 | 595,688,000 |
| Jun 2026 | 125,757,000 | 80,517,000 | -8,364,000 | -13,510,000 | 1,071,934,000 | 77,316,000 | 626,349,000 |
| Mar 2026 | 116,337,000 | 75,448,000 | 5,787,000 | 1,417,000 | 883,157,000 | 55,764,000 | 432,690,000 |
| Dec 2025 | 115,992,000 | 73,143,000 | 7,180,000 | 2,426,000 | 884,796,000 | 64,908,000 | 436,564,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$41,710,000
Investing CF
$-175,028,000
Financing CF
$157,598,000
CapEx
$-50,867,000
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-0.07
As of
2026-11-08
Balance + Analyst (yfinance extras)
Retained Earnings
$-63,591,000
Inventory
$103,364,000
Receivables
$110,763,000
ST Investments
—
EBIT TTM
$26,502,000
Pretax Income TTM
$2,233,000
Interest Exp TTM
$24,269,000
Analysts
9
Yahoo Snapshot (yfinance, live)
Total Revenue
$481,876,000
EBITDA
$55,557,000
Free Cash Flow
$-48,241,248
Enterprise Value
$1,344,673,920
Total Cash
$48,399,000
Total Debt
$407,027,008
Shares Out
48,790,000
Trailing EPS
$-0.36
Book Value
$9.15
ROE
-4.0%
ROA
1.9%
Div Yield
0.00%
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 441,330,000 | 26,745,000 | 9,768,000 | 884,796,000 | 436,564,000 | 448,232,000 | 39,880,000 |
| Dec 2024 | 388,537,000 | 38,874,000 | -13,359,000 | 789,101,000 | 512,901,000 | 276,200,000 | 22,236,000 |
| Dec 2023 | 354,004,000 | -8,508,000 | -30,690,000 | 792,397,000 | 510,617,000 | 281,780,000 | 18,825,000 |
| Dec 2022 | 313,789,000 | 6,201,000 | -19,192,000 | 762,798,000 | 478,469,000 | 284,329,000 | -5,153,000 |
TTM Snapshot
Revenues TTM
$471,474,000
NetIncome TTM
$-3,165,000
OpCashFlow TTM
—
Assets (Latest)
$1,071,934,000
Forward EPS
$0.63
Max Pain — expiry 2027-04-16 (volume-derived — Yahoo OI feed degraded)
max pain strike: $15.00 · spot: $18.54 · call volume: 114 · put volume: 6
Expected Move to 2027-04-16:
±$4.83
(26.02%) —
implied range
$13.72 –
$23.37
· ATM straddle on $17.50 strike
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| KIDS | ORTHOPEDIATRICS CORP | $820.13M | $31.41 | — |
| BBNX | Beta Bionics, Inc. | $800.28M | $14.72 | — |
| CBLL | Ceribell, Inc. | $1.01B | $25.97 | — |
| SIBN | SI-BONE, Inc. | $1.04B | $23.16 | — |
| STVN | Stevanato Group S.p.A. | $759.94M | $15.25 | — |
News headlines (Yahoo Finance, 1h cache)
AORT Q3 2026 deep dive: stent graft growth and NEXUS launch preparations shape outlook
2026-11-10 13:17 · Yahoo
Artivion (AORT) Stock Looks About Right Following Nexus Launch Preparations
2026-11-10 06:11 · Yahoo
Artivion Q3 Earnings Call Highlights
2026-11-07 00:14 · Yahoo
Artivion, Inc. Q3 2026 Earnings Call Summary
2026-11-06 13:30 · Yahoo
Artivion Inc (AORT) (Q3 2026) Earnings Call Highlights: Stent Graft Momentum and Nexus Launch ...
2026-11-06 09:20 · Yahoo
What Artivion (AORT)'s Revenue Growth And Loss Mean For Shareholders
2026-11-06 08:12 · Yahoo
Artivion (AORT) Q3 2026 Earnings Call Transcript
2026-11-06 06:46 · Yahoo
Artivion (AORT) Lags Q3 Earnings Estimates
2026-11-05 21:45 · Yahoo
Artivion’s (NYSE:AORT) Q3 2026 sales beat estimates
2026-11-05 21:36 · Yahoo
Artivion: Q3 Earnings Snapshot
2026-11-05 21:16 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.